Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantheus

90.92
-6.2900-6.47%
Post-market: 90.920.00000.00%17:20 EDT
Volume:1.16M
Turnover:105.59M
Market Cap:6.24B
PE:20.85
High:93.86
Open:92.49
Low:89.12
Close:97.21
Loading ...

Lantheus Holdings Inc - FY 2025 Revenue Guidance: $1.545 Billion - $1.610 Billion

THOMSON REUTERS
·
26 Feb

Lantheus Holdings Inc FY2025 Shr View $6.95, REV View $1.60 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
26 Feb

Lantheus Holdings Inc Outlook FY 2025 Adjusted Fully Diluted EPS $7.00 - $7.20

THOMSON REUTERS
·
26 Feb

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

GlobeNewswire
·
26 Feb

Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow

StockStory
·
25 Feb

Investors in Lantheus Holdings (NASDAQ:LNTH) have seen incredible returns of 406% over the past five years

Simply Wall St.
·
25 Feb

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Stoke Therapeutics (STOK) and Lantheus (LNTH)

TIPRANKS
·
23 Feb

Lantheus to Present at Upcoming Investor Conferences

GlobeNewswire
·
21 Feb

Lantheus Holdings Inc : Leerink Partners Raises Target Price to $125 From $122

THOMSON REUTERS
·
19 Feb

B. Riley Adjusts Lantheus Holdings Price Target to $127 From $146, Maintains Buy Rating

MT Newswires Live
·
12 Feb

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

GlobeNewswire
·
12 Feb

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

GlobeNewswire
·
05 Feb

With EPS Growth And More, Lantheus Holdings (NASDAQ:LNTH) Makes An Interesting Case

Simply Wall St.
·
05 Feb

Lantheus Holdings, Inc. (LNTH): Among the Best Low Risk High Growth Stocks To Invest In Now

Insider Monkey
·
05 Feb

Lantheus Appoints Dr. Morrow to Board of Directors

TIPRANKS
·
30 Jan

Lantheus appoints Morrow as new board member

TIPRANKS
·
30 Jan

Lantheus Appoints Phuong Khanh (P.k.) Morrow, M.d., as New Board Member

THOMSON REUTERS
·
30 Jan

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

GlobeNewswire
·
30 Jan

Lantheus’s Strategic Acquisition of Evergreen Theragnostics Strengthens Radiopharmaceutical Leadership and Growth Prospects

TIPRANKS
·
30 Jan

LNTH: Evergreen Acquisition Promotes Future Innovation

Zacks Small Cap Research
·
30 Jan